Zevra Therapeutics (ZVRA) Receivables - Net (2016 - 2026)
Zevra Therapeutics' Receivables - Net came in at $22.49 million for Q2 2026, up 23.1% from $18.27 million a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Receivables - Net (2016 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Receivables - Net was $23.26 million, up 121.3% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of 55.2% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $10.51 million in FY2024 (-39.5%), $17.38 million in FY2023 (+109.4%), $8.3 million in FY2022 (+443.1%) and $1.53 million in FY2021 (-40.8%).
- The five-year range for quarterly Receivables - Net is $1.53 million (Q4 2021) to $23.26 million (Q4 2025).
- Year-over-year, Receivables - Net has increased for six consecutive quarters, with growth averaging 53.8% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2022 (growth of 713.2%), and the weakest in Q1 2024 (a decline of 46.9%).
- Business Quant data shows ZVRA's Receivables - Net at $22.1 million (Q1 2026), $23.26 million (Q4 2025) and $16.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Zevra Therapeutics | 672.94 Mn | -139.77 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.49 Mn |
| Mar 31, 2026 | 22.10 Mn |
| Dec 31, 2025 | 23.26 Mn |
| Sep 30, 2025 | 16.84 Mn |
| Jun 30, 2025 | 18.27 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Dec 31, 2024 | 10.51 Mn |
| Sep 30, 2024 | 7.79 Mn |
| Jun 30, 2024 | 8.95 Mn |
| Mar 31, 2024 | 8.31 Mn |
| Dec 31, 2023 | 17.38 Mn |
| Sep 30, 2023 | 9.93 Mn |
| Jun 30, 2023 | 14.03 Mn |
| Mar 31, 2023 | 15.64 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 13.17 Mn |
| Jun 30, 2022 | 5.64 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.62 Mn |
API Access
Zevra Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();